• Subject: RE: Cross-reference utilities
  • From: Joe Giusto <JDG@xxxxxxxxxxxx>
  • Date: Thu, 9 Jul 1998 07:46:44 -0400

OCL is tuff.  but i think Documint works on OCL.  they sent me a demo
but i stopped looking at it when it wouldn't do the RPG4 (although i
think they said it's in the works.)

> -----Original Message-----
> From: Joe Teff [SMTP:jteff19@idt.net]
> Sent: Wednesday, July 08, 1998 6:50 PM
> To:   'MidrangeDotCom'
> Subject:      Cross-reference utilities
> 
> I have used several cross-reference utilities in the past including
> Hawkeye and
> Abstract/Probe. I am faced with a client that has a significant number
> of S/36 environment
> code including OCL. They have a few RPG/ILE programs as well. Does
> anyone have
> experience with cross-reference products that cover OCL, CL, RPG2,
> RPG3, RPG4, etc. I have not had to deal with OCL in the past. Thanks.
> 
> Joe Teff
> Information Technology Consultant
> IBM Certified Specialist - AS/400 RPG Programmer
> Quality Data Systems
> Minneapolis, MN
> 
> +---
> | This is the Midrange System Mailing List!
> | To submit a new message, send your mail to MIDRANGE-L@midrange.com.
> | To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
> | To unsubscribe from this list send email to
> MIDRANGE-L-UNSUB@midrange.com.
> | Questions should be directed to the list owner/operator:
> david@midrange.com
> +---
+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---


This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].